DEC 15, 2018 11:57 PM PST

Ebola-Fighting Protein Paves The Way For New Drugs

WRITTEN BY: Nouran Amin

In a study published in Cell, research at Northwestern University School of Medicine has involved scientists discovering a human protein that could be the key to eradicating the Ebola virus—opening the doors to possible drug therapies. The discovered protein is called RBBP6 and works by interfering with the Ebola virus replication inhibiting its survival.

 

 

"One of the scariest parts about the 2014 Ebola outbreak was that we had no treatments on hand; tens of thousands of people became sick and thousands of people died because we lacked a suitable treatment," Hultquist said. "What we envision is a small molecule drug that mimics this human protein and could be used in response to an Ebola virus outbreak."

Viruses develop proteins that evolve to develop even more advanced proteins that bypass the body’s immune defense system. Interestingly, human cells in turn also evolve new defense mechanisms against those viruses producing an evolutionary arms race with a therapeutic potential.

"It wasn't until the outbreak of 2014 that other countries started seriously worrying about the potential for a larger epidemic," Hultquist said. "It's no longer going to be a local problem that people can afford to ignore. We should be taking a much more proactive stance against some of these neglected viruses and be studying them in real time -- so the next time an outbreak does occur, we're ready for it."

Ebola-fighting protein discovered in human cells.

Credit: Northwestern University

The research study is hoping to gear towards the development of a small drug molecule that is able to enter human cells more easily for treatment. Their studies using structural and computational analysis has narrowed their research to a small peptide consisting of 23 amino acids. The small peptide chain was found to be efficient enough to disrupt the Ebola virus.

"If you take that peptide and put it into human cells, you can block Ebola virus infection," Hultquist said. "Conversely, when you remove the RBBP6 protein from human cells, Ebola virus replicates much faster."

Source: Science Daily

 

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 09, 2018
Drug Discovery
OCT 09, 2018
'Copper Antibiotic Peptide' Effective in Eradicating Tuberculosis
The bacterium responsible for Tuberculosis has found a way to avoid antibiotics by hiding inside the macrophages which are the specific immune cells that a...
NOV 08, 2018
Health & Medicine
NOV 08, 2018
Is Daily Aspirin Safe For Heart Attack Prevention
The benefits of aspirin use in patients with known cardiovascular disease (CVD) are well-established. A 2015 meta-analysis reviewed data gathered from 118,...
NOV 21, 2018
Drug Discovery
NOV 21, 2018
Drug Could Seek New Approach For Autoimmunity
From a failed pain drug, a protein called ‘BH4’, was recently discovered to have surprising implications in the treatment of autoimmunity and c...
DEC 23, 2018
Drug Discovery
DEC 23, 2018
Preventive Drug Decreases Cases of Leprosy in Morocco
Leprosy, also known as Hansen disease, is a disabling chronic and infectious disease that affects the skin and the peripheral nerves. It has a huge effect ...
JAN 17, 2019
Microbiology
JAN 17, 2019
Ulcerative Colitis Relieved by Fecal Microbiota Transplant
The community of microbes in our gut is critical to our health. If it's out of balance, researchers are investigating whether 'healthy' fecal material can restore it....
FEB 11, 2019
Chemistry & Physics
FEB 11, 2019
Actinium-based Targeted Alpha Therapy Delivers A Combo Punch
Radiotherapy is a staple among many medical interventions to treat cancer. Besides external beam radiotherapy and sealed radio-source therapy, it is common...
Loading Comments...